NASH and NAFLD: Case Based Discussion.

Case Based Discussion on Non-alcoholic steatohepatitis (NASH) and Non-alcoholic fatty liver disease (NAFLD)

Published On 2021-10-06T16:29:14+05:30 | Updated On 6 Oct 2021 10:59 AM GMT

Overview

The overall global prevalence of NAFLD is estimated to be around 25.24% according to an analysis made with statistical approach. The highest prevalence is reported from the Middle East with 31.79%, followed by South America with 30.45% and the least prevalent rate is reported from Africa with 13.48%. The prevalence of NASH in general population is estimated to be in the range of 1.5% and 6.45%. NASH is estimated to be prevalent in 59.10% of NAFLD population. It is estimated that 16-32% of general population in India (nearly 120 million) has NAFLD and among them nearly 31% are diagnosed with NASH. Industrialization and change in lifestyle and diet with less physical activity and increased calorie rich food are contributing to the increased prevalence of NAFLD in Indian population. In this video, Dr Dinesh Jothimani discuss NASH and NAFLD based on clinical cases.

This video is a part of the JBCPL body of knowledge conclave 2021. check out the entire conclave at https://medicaldialogues.in/JBCPL-BOK

Speakers

Dr Dinesh Jothimani

MRCP (UK), FRCP (Glasgow), CCT (Hepatology, Gastroenterology & General Medicine).

Dr. Dinesh Jothimani is a Hepatologist and Gastroenterologist with over 18 years of experience. He completed his MBBS from The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU) in 2000 and MRCP (UK) from Royal College of Physician, London in 2004. He is a member of the Indian Association for the study of Liver, Indian Society of Gastroenterology, General Medical Council (GMC), UK, European Association of Study of Liver, British Association of Study of Liver and Fellowship in Royal College of Physicians.